Randy Teel, Ph.D. is recorded as CEO and Board Member at Arvinas, Inc. (ARVN) since February 12, 2026. Arvinas, Inc. reported in an 8-K filed February 12, 2026 that Randy Teel, Ph.D. was appointed president, CEO, and principal executive officer, effective February 12, 2026. Arvinas, Inc. reported in an 8-K filed February 12, 2026 that Randy Teel, Ph.D. was appointed member of the Board, effective February 12, 2026. Randy Teel, Ph.D. has spoken on 1 earnings call across 1 company, most recently for Arvinas, Inc. on May 12, 2026. Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Briggs Morrison, M.D. (Chairman), Randy Teel (CFO), David Loomis (Chief Accounting Officer) and 6 others.
“On February 11, 2026, the Board appointed Randy Teel, Ph.D., as the Company's president, CEO, and principal executive officer, and a member of the Board, effective as of the Effective Date.”
Arvinas, Inc. Form 8-K, filed February 12, 2026
· Read the filing
“On February 11, 2026, the Board appointed Randy Teel, Ph.D., as the Company's president, CEO, and principal executive officer, and a member of the Board, effective as of the Effective Date.”
Arvinas, Inc. Form 8-K, filed February 12, 2026
· Read the filing
Randy Teel, Ph.D. on recent calls
“Since stepping into the role as CEO earlier this year, my appreciation for the strength of the Arvinas platform, the talent and execution capability of our team, and our deep and differentiated pipeline has only grown.”
